Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LISA G ABBOTT

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1609883701
CMS profile
344804
Location
RENO, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$4,607.20

122 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Page 3 of 3; records 101–122 of 122 matching records. This page contains 22 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LISA G ABBOTT

NPI 1609883701 · CMS profile ID 344804

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

RENO, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–122 of 122 matching records. This page contains 22 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1609883701?year=2020&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LISA G ABBOTT, NPI 1609883701, CMS profile ID 344804. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–122 of 122 matching records. This page contains 22 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1609883701?year=2020&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). LISA G ABBOTT, NPI 1609883701, CMS profile ID 344804. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–122 of 122 matching records. This page contains 22 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1609883701?year=2020&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
LISA G ABBOTT, NPI 1609883701, CMS profile ID 344804, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–122 of 122 matching records. This page contains 22 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1609883701?year=2020&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

122 matching records · $4,607.20 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 122 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–122 of 122.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Abbott Laboratories $24.4002/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749027927 CMS
Radius Health, Inc. $13.2502/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746291741 CMS
Amarin Pharma Inc. $13.8102/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740074337 CMS
Amarin Pharma Inc. $7.1602/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740074333 CMS
Mannkind Corporation $19.5102/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752665939 CMS
Novo Nordisk Inc $104.5902/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744636609 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.1302/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721007577 CMS
Corcept Therapeutics $56.7902/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744731043 CMS
Antares Pharma, Inc. $14.7901/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751427541 CMS
Janssen Pharmaceuticals, Inc $16.9601/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719267969 CMS
Amgen Inc. $9.8001/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741199739 CMS
Merck Sharp & Dohme Corporation $13.9701/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747697201 CMS
AbbVie Inc. $19.4401/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721659199 CMS
Lilly USA, LLC $5.6701/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728539255 CMS
AstraZeneca Pharmaceuticals LP $104.3201/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735957425 CMS
Companion Medical, Inc. $18.8701/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 714617903 CMS
Companion Medical, Inc. $103.9301/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 714617907 CMS
Ultragenyx Pharmaceutical Inc. $16.0401/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723160655 CMS
Radius Health, Inc. $86.5201/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746291757 CMS
Tandem Diabetes Care, Inc. $96.6701/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750763561 CMS
AstraZeneca Pharmaceuticals LP $16.5101/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736169447 CMS
Insulet Corporation $23.8701/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748413173 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $27,100.98 162
PY2020 $4,607.20 122
PY2021 $10,660.31 119
PY2022 $6,205.50 110
PY2023 $27,522.16 146
PY2024 $3,915.36 112
PY2025 $49,858.94 176

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $365,890.09 71
PY2024 Recipient $9,760.14 15
PY2024 Principal investigator $369,762.22 168
PY2023 Recipient $2,004.84 1
PY2023 Principal investigator $110,086.26 16
PY2022 Recipient $156.24 1
PY2022 Principal investigator $184,967.77 26
PY2021 Recipient $5,703.44 2
PY2021 Principal investigator $29,410.00 7
PY2020 Recipient $1,215.00 2
PY2020 Principal investigator $29,700.00 4
PY2019 Recipient $26,409.70 9
PY2019 Principal investigator $19,360.00 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

71 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $5,612.00 12/31/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INSTITUTE OF NORTHERN NEVADA
A Phase 2/3 multicenter, double blinded, randomized, dose-conversion, active control study examining the efficacy and safety of Armour Thyroid compared to synthetic T4 for the treatment of adults with primary hypothyroidism No dispute reported 06/30/2026 1202533873
Principal investigator 1 Novo Nordisk AS $945.27 12/22/2025 Non-covered Recipient Entity
NORTHERN NEVADA ENDOCRINOLOGY
NN8640-4515 No dispute reported 06/30/2026 1214103790
Principal investigator 1 ABBVIE INC. $29,109.04 12/05/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INSTITUTE OF
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202529346
Principal investigator 1 ABBVIE INC. $26,385.87 11/05/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INSTITUTE OF
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202522269
Principal investigator 1 Ascendis Pharma Endocrinology Inc $830.00 11/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233997318
Principal investigator 1 Ascendis Pharma Endocrinology Inc $830.00 11/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233997320
Principal investigator 1 Ascendis Pharma Endocrinology Inc $830.00 11/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233997322
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 11/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233997416
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 11/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233997418
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 11/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233997420
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 11/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233997422
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 11/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233997424
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 11/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233997426
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 11/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233997428
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 11/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233997430
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 11/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233997432
Principal investigator 1 ABBVIE INC. $27,722.52 10/09/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INSTITUTE OF
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202513915
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $680.00 10/09/2025 Non-covered Recipient Entity
NORTHERN NEVADA ENDOCRINOLOGY
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 1223286669
Principal investigator 1 Ascendis Pharma Endocrinology Inc $855.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996785
Principal investigator 1 Ascendis Pharma Endocrinology Inc $830.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996787
Principal investigator 1 Ascendis Pharma Endocrinology Inc $830.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996789
Principal investigator 1 Ascendis Pharma Endocrinology Inc $830.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996791
Principal investigator 1 Ascendis Pharma Endocrinology Inc $830.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996793
Principal investigator 1 Ascendis Pharma Endocrinology Inc $830.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996795
Principal investigator 1 Ascendis Pharma Endocrinology Inc $830.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996797
Principal investigator 1 Ascendis Pharma Endocrinology Inc $830.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996799
Principal investigator 1 Ascendis Pharma Endocrinology Inc $830.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996801
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996823
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996825
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996827
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996829
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996831
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996833
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996835
Principal investigator 1 Ascendis Pharma Endocrinology Inc $560.00 09/11/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996837
Principal investigator 1 ABBVIE INC. $25,802.66 09/04/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INSTITUTE OF
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202509578
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $680.00 09/04/2025 Non-covered Recipient Entity
NORTHERN NEVADA ENDOCRINOLOGY
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 1223285111
Principal investigator 1 Alexion Pharmaceuticals, Inc. $922.63 09/03/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INSTITUTE OF NORTHERN NEVADA
Eneboparatide - Calypso study which is a pivotal phase 3 study investigational therapeutic peptide with a novel mechanism of action for hypoparathyroidism No dispute reported 06/30/2026 1185553309
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $8,840.00 08/21/2025 Non-covered Recipient Entity
NORTHERN NEVADA ENDOCRINOLOGY
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 1223284491
Principal investigator 1 ABBVIE INC. $42,145.04 08/06/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INSTITUTE OF
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202502462
Principal investigator 1 Ascendis Pharma Endocrinology Inc $738.00 07/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996205
Principal investigator 1 Ascendis Pharma Endocrinology Inc $228.00 07/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996431
Principal investigator 1 Ascendis Pharma Endocrinology Inc $152.00 07/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996433
Principal investigator 1 Ascendis Pharma Endocrinology Inc $76.00 07/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996455
Principal investigator 1 Ascendis Pharma Endocrinology Inc $76.00 07/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996457
Principal investigator 1 Ascendis Pharma Endocrinology Inc $76.00 07/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996459
Principal investigator 1 Ascendis Pharma Endocrinology Inc $76.00 07/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996461
Principal investigator 1 Ascendis Pharma Endocrinology Inc $76.00 07/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996463
Principal investigator 1 Ascendis Pharma Endocrinology Inc $76.00 07/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996465
Principal investigator 1 Ascendis Pharma Endocrinology Inc $76.00 07/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996467
Principal investigator 1 Ascendis Pharma Endocrinology Inc $76.00 07/03/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996469
Principal investigator 1 ABBVIE INC. $17,178.28 07/02/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INSTITUTE OF
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202494011
Principal investigator 1 Ascendis Pharma Endocrinology Inc $1,243.75 06/20/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
PaTHway TRIAL No dispute reported 06/30/2026 1233995927
Principal investigator 1 ABBVIE INC. $18,533.55 06/03/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INSTITUTE OF
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202488303
Principal investigator 1 ABBVIE INC. $12,462.76 05/07/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INSTITUTE OF
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202482349
Principal investigator 1 Ascendis Pharma Endocrinology Inc $2,062.50 04/21/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
PaTHway TRIAL No dispute reported 06/30/2026 1233995527
Principal investigator 1 Novo Nordisk AS $3,781.08 04/21/2025 Non-covered Recipient Entity
NORTHERN NEVADA ENDOCRINOLOGY
NN8640-4515 No dispute reported 06/30/2026 1214102997
Principal investigator 1 ABBVIE INC. $4,658.99 04/03/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INSTITUTE OF
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202471142
Principal investigator 1 Ascendis Pharma Endocrinology Inc $20,943.52 03/26/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
PaTHway TRIAL No dispute reported 06/30/2026 1233995231
Principal investigator 1 ABBVIE INC. $14,493.01 03/07/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INSTITUTE OF
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202459215
Principal investigator 1 Alexion Pharmaceuticals, Inc. $25,745.06 03/05/2025 Non-covered Recipient Entity
NORTHERN NEVADA ENDOCRINOLOGY
Eneboparatide - Calypso study which is a pivotal phase 3 study investigational therapeutic peptide with a novel mechanism of action for hypoparathyroidism No dispute reported 06/30/2026 1185553311
Principal investigator 1 Ascendis Pharma Endocrinology Inc $855.00 03/05/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233995001
Principal investigator 1 Ascendis Pharma Endocrinology Inc $855.00 03/05/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233995003
Principal investigator 1 Ascendis Pharma Endocrinology Inc $855.00 03/05/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233995005
Principal investigator 1 Ascendis Pharma Endocrinology Inc $855.00 03/05/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233995007
Principal investigator 1 Ascendis Pharma Endocrinology Inc $1,593.75 02/18/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
PaTHway TRIAL No dispute reported 06/30/2026 1233994841
Principal investigator 1 ABBVIE INC. $5,644.52 02/06/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INSTITUTE OF
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202448029
Principal investigator 1 Eli Lilly and Company $1,286.84 01/31/2025 Covered Recipient Teaching Hospital
LOGAN HEALTH MEDICAL CENTER
A STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND OBESITY OR OVERWEIGHT AT INCREASED CARDIOVASCULAR RISK (ACHIEVE-4) No dispute reported 06/30/2026 1187872323
Principal investigator 1 Novo Nordisk AS $4,661.95 01/31/2025 Non-covered Recipient Entity
NORTHERN NEVADA ENDOCRINOLOGY
NN8640-4515 No dispute reported 06/30/2026 1214104245
Principal investigator 1 Ascendis Pharma Endocrinology Inc $4,522.50 01/23/2025 Non-covered Recipient Entity
Lisa G Abbott, MD A Professional Corporation
PaTHway TRIAL No dispute reported 06/30/2026 1233994394
Principal investigator 1 Eli Lilly and Company $33,582.00 01/07/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INSTITUTE OF NORTHERN NEVADA
A STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND OBESITY OR OVERWEIGHT AT INCREASED CARDIOVASCULAR RISK (ACHIEVE-4) No dispute reported 06/30/2026 1187879469